NCT01733485View on ClinicalTrials.gov

Electrophilic Fatty Acid Derivatives in Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

September 30, 2016

Study Completion Date

June 30, 2017

Conditions
AsthmaElectrophilic Fatty Acids
Interventions
DRUG

Aspirin

500 mg/8 h for 5 days

DRUG

Indomethacin

25 mg/8 h for 5 days

Trial Locations (1)

15213

University of Pittsburgh, Pittsburgh

All Listed Sponsors
lead

Sally E. Wenzel MD

OTHER

NCT01733485 - Electrophilic Fatty Acid Derivatives in Asthma | Biotech Hunter | Biotech Hunter